NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Probabilistic Assessment of Hypobaric Decompression Sickness Treatment SuccessThe Hypobaric Decompression Sickness (DCS) Treatment Model links a decrease in computed bubble volume from increased pressure (DeltaP), increased oxygen (O2) partial pressure, and passage of time during treatment to the probability of symptom resolution [P(symptom resolution)]. The decrease in offending volume is realized in 2 stages: a) during compression via Boyle's Law and b) during subsequent dissolution of the gas phase via the O2 window. We established an empirical model for the P(symptom resolution) while accounting for multiple symptoms within subjects. The data consisted of 154 cases of hypobaric DCS symptoms along with ancillary information from tests on 56 men and 18 women. Our best estimated model is P(symptom resolution) = 1 / (1+exp(-(ln(Delta P) - 1.510 + 0.795×AMB - 0.00308×Ts) / 0.478)), where (DeltaP) is pressure difference (psid), AMB = 1 if ambulation took place during part of the altitude exposure, otherwise AMB = 0; and where Ts is the elapsed time in mins from start of the altitude exposure to recognition of a DCS symptom. To apply this model in future scenarios, values of DeltaP as inputs to the model would be calculated from the Tissue Bubble Dynamics Model based on the effective treatment pressure: (DeltaP) = P2 - P1 | = P1×V1/V2 - P1, where V1 is the computed volume of a spherical bubble in a unit volume of tissue at low pressure P1 and V2 is computed volume after a change to a higher pressure P2. If 100% ground level O2 (GLO) was breathed in place of air, then V2 continues to decrease through time at P2 at a faster rate. This calculated value of (DeltaP then represents the effective treatment pressure at any point in time. Simulation of a "pain-only" symptom at 203 min into an ambulatory extravehicular activity (EVA) at 4.3 psia on Mars resulted in a P(symptom resolution) of 0.49 (0.36 to 0.62 95% confidence intervals) on immediate return to 8.2 psia in the Multi-Mission Space Exploration Vehicle. The P(symptom resolution) increased to near certainty (0.99) after 2 hrs of GLO at 8.2 psia or with less certainty on immediate pressurization to 14.7 psia [0.90 (0.83 - 0.95)]. Given the low probability of DCS during EVA and the prompt treatment of a symptom with guidance from the model, it is likely that the symptom and gas phase will resolve with minimum resources and minimal impact on astronaut health, safety, and productivity.
Document ID
20140012081
Acquisition Source
Johnson Space Center
Document Type
Contractor or Grantee Report
Authors
Conkin, Johnny
(Universities Space Research Association Houston, TX, United States)
Abercromby, Andrew F. J.
(Wyle Science, Technology and Engineering Houston, TX, United States)
Dervay, Joseph P.
(NASA Johnson Space Center Houston, TX, United States)
Feiveson, Alan H.
(NASA Johnson Space Center Houston, TX, United States)
Gernhardt, Michael L.
(NASA Johnson Space Center Houston, TX, United States)
Norcross, Jason R.
(Wyle Science, Technology and Engineering Houston, TX, United States)
Ploutz-Snyder, Robert
(Universities Space Research Association Houston, TX, United States)
Wessel, James H., III
(Wyle Science, Technology and Engineering Houston, TX, United States)
Date Acquired
September 18, 2014
Publication Date
January 1, 2014
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-31426
Funding Number(s)
CONTRACT_GRANT: NNJ11HE31A
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available